Theodore Friedman to Electronic Nicotine Delivery Systems
This is a "connection" page, showing publications Theodore Friedman has written about Electronic Nicotine Delivery Systems.
Connection Strength
3.907
-
The lipolysis inhibitor acipimox reverses the cardiac phenotype induced by electronic cigarettes. Sci Rep. 2023 10 25; 13(1):18239.
Score: 0.797
-
Last Word on Viewpoint: pH Buffer capacity and pharmacokinetics: two remaining questions. J Appl Physiol (1985). 2020 04 01; 128(4):1063-1064.
Score: 0.623
-
Pod-mod vs. conventional e-cigarettes: nicotine chemistry, pH, and health effects. J Appl Physiol (1985). 2020 04 01; 128(4):1056-1058.
Score: 0.611
-
A mouse model for chronic intermittent electronic cigarette exposure exhibits nicotine pharmacokinetics resembling human vapers. J Neurosci Methods. 2019 10 01; 326:108376.
Score: 0.594
-
Chronic intermittent electronic cigarette exposure induces cardiac dysfunction and atherosclerosis in apolipoprotein-E knockout mice. Am J Physiol Heart Circ Physiol. 2019 08 01; 317(2):H445-H459.
Score: 0.589
-
E-Cigarette Smoke Exposure Elevates Renal MR Expression and Induces BP Elevation. Hypertension. 2025 Sep; 82(9):1492-1504.
Score: 0.224
-
Adverse effects of fetal exposure of electronic-cigarettes and high-fat diet on male neonatal hearts. Exp Mol Pathol. 2021 02; 118:104573.
Score: 0.163
-
Electronic cigarettes cause alteration in cardiac structure and function in diet-induced obese mice. PLoS One. 2020; 15(10):e0239671.
Score: 0.161
-
E-cigarettes and Western Diet: Important Metabolic Risk Factors for Hepatic Diseases. Hepatology. 2019 06; 69(6):2442-2454.
Score: 0.145